Tufts Medical Center
Cardiovascular Disease fellowship · Boston, MA · Program website
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Tufts Medical Center's research in cardiovascular disease, which the program shares with other departments and affiliated hospitals.
About Tufts Medical Centerinstitution-wide cardiovascular disease research
Cardiovascular Disease publications from Tufts Medical Center and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
150
works per year
25th of 80 cardiovascular disease fellowship programs
+4.8%
2-year growth
52nd of 80 cardiovascular disease fellowship programs
29.0%
in top 10% of field (works before 2025)
26th of 76 cardiovascular disease fellowship programs
44.5%
cited above world average
32nd of 76 cardiovascular disease fellowship programs
Works per year · * 2026 so far
Cardiology and Cardiovascular Medicine · 701
Cardiovascular Disease research topics at Tufts Medical Center
Papers in the window; each links to the list on OpenAlex.
- Mechanical Circulatory Support Devices 240
- Heart Failure Treatment and Management 104
- Cardiomyopathy and Myosin Studies 55
- Cardiac Valve Diseases and Treatments 52
- Atrial Fibrillation Management and Outcomes 49
- Cardiac pacing and defibrillation studies 22
- Chemotherapy-induced cardiotoxicity and mitigation 18
- Cardiac Fibrosis and Remodeling 15
Most cited at Tufts Medical Center since 2024
All cardiovascular disease papers there on OpenAlex
- Reperfusion Injury in Patients With Acute Myocardial InfarctionFrederick G.P. Welt et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 263
- Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort studyNicklas Vinter et al. · BMJ · 2024 · PubMed · cited 122
- Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of AmericaMichelle Weisfelner Bloom et al. · Journal of Cardiac Failure · 2024 · PubMed · cited 120
- Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialJaved Butler et al. · The Lancet · 2025 · PubMed · cited 99
- Serial Shock Severity Assessment Within 72 Hours After DiagnosisVan‐Khue Ton et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 78
- Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathyRafik Tadros et al. · Nature Genetics · 2025 · PubMed · cited 72
- Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working GroupJ. Fried et al. · The Journal of Heart and Lung Transplantation · 2024 · PubMed · cited 69
- Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic CardiomyopathyMartin S. Maron et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 69
- Postoperative Aspiration Pneumonia Among Adults Using GLP-1 Receptor AgonistsYuan-Hsin Chen et al. · JAMA Network Open · 2025 · PubMed · cited 65
- Seated Pulmonary Artery Pressure Monitoring in Patients With Heart FailureJason L. Guichard et al. · JACC Heart Failure · 2024 · PubMed · cited 59